Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard Moise

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Human Vaccines & Immunotherapeutics|June 20, 2015
H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated toleranceRui Liu, Leonard Moise, Ryan Tassone, et al.
Human Vaccines & Immunotherapeutics|July 18, 2018
T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and responseLeonard Moise, Bethany M Biron, Christine M Boyle, et al.
Human Vaccines & Immunotherapeutics|June 3, 2017
An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic miceCallie E Bounds, Frances E Terry, Leonard Moise, et al.
Human Vaccines & Immunotherapeutics|September 19, 2013
Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic miceLeonard Moise, Ryan Tassone, Howard Latimer, et al.
Human Vaccines & Immunotherapeutics|December 18, 2014
Partial pathogen protection by tick-bite sensitization and epitope recognition in peptide-immunized HLA DR3 transgenic miceWendy M C Shattuck, Megan C Dyer, Joe Desrosiers, et al.
Immunology and Cell Biology|November 12, 2014
C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cellsAnne S De Groot, Ted M Ross, Lauren Levitz, et al.
Plos One|April 18, 2014
Human immune responses to H. pylori HLA Class II epitopes identified by immunoinformatic methodsSonghua Zhang, Joseph Desrosiers, Jose R Aponte-Pieras, et al.
NPJ Vaccines|May 14, 2021
Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validationLauren M Meyers, Andres H Gutiérrez, Christine M Boyle, et al.
Human Vaccines & Immunotherapeutics|June 25, 2015
An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopesChristopher S Eickhoff, Daniel Van Aartsen, Frances E Terry, et al.
Molecular Therapy. Methods & Clinical Development|July 8, 2015
Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillanceKristina Blazanovic, Hongliang Zhao, Yoonjoo Choi, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Human Vaccines & Immunotherapeutics|June 20, 2015
H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated toleranceRui Liu, Leonard Moise, Ryan Tassone, et al.
Human Vaccines & Immunotherapeutics|July 18, 2018
T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and responseLeonard Moise, Bethany M Biron, Christine M Boyle, et al.
Human Vaccines & Immunotherapeutics|June 3, 2017
An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic miceCallie E Bounds, Frances E Terry, Leonard Moise, et al.
Human Vaccines & Immunotherapeutics|September 19, 2013
Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic miceLeonard Moise, Ryan Tassone, Howard Latimer, et al.
Human Vaccines & Immunotherapeutics|December 18, 2014
Partial pathogen protection by tick-bite sensitization and epitope recognition in peptide-immunized HLA DR3 transgenic miceWendy M C Shattuck, Megan C Dyer, Joe Desrosiers, et al.
Immunology and Cell Biology|November 12, 2014
C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cellsAnne S De Groot, Ted M Ross, Lauren Levitz, et al.
Plos One|April 18, 2014
Human immune responses to H. pylori HLA Class II epitopes identified by immunoinformatic methodsSonghua Zhang, Joseph Desrosiers, Jose R Aponte-Pieras, et al.
NPJ Vaccines|May 14, 2021
Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validationLauren M Meyers, Andres H Gutiérrez, Christine M Boyle, et al.
Human Vaccines & Immunotherapeutics|June 25, 2015
An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopesChristopher S Eickhoff, Daniel Van Aartsen, Frances E Terry, et al.
Molecular Therapy. Methods & Clinical Development|July 8, 2015
Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillanceKristina Blazanovic, Hongliang Zhao, Yoonjoo Choi, et al.
Pageof 8